Measures of Disease Frequency

  • Bryan Kestenbaum

Learning Objectives

  1. 1.
    Measures of disease frequency:
    1. a.

      Clarify the significance of a particular health problem

    2. b.

      Help guide resource allocation

    3. c.

      Provide basic insight into the pathogenesis of disease

  2. 2.

    Point prevalence describes the amount of disease at a particular point in time.

  3. 3.

    Incidence describes the number of new cases of disease that develop over time.

  4. 4.

    Incidence may be expressed as incidence proportion or incidence rate.

  5. 5.

    Incidence rate accounts for follow-up time

  6. 6.

    Measures of disease frequency can be stratified, or broken up, by person, place, or time characteristics to gain insight into a disease process.



Multiple Sclerosis Chronic Kidney Disease Cesarean Section Polycythemia Vera Sunlight Exposure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Hyman DJ, Henry A, Taylor A. Severe rhabdomyolysis related to cerivastatin without gemfibrozil. Ann Intern Med. Jul 2 2002;137(1):74.PubMedGoogle Scholar
  2. 2.
    Psaty BM, Furberg CD, Ray WA, Weiss NS. Potential for conflict of interest in the evaluation of suspected adverse drug reactions: use of cerivastatin and risk of rhabdomyolysis. JAMA. Dec 1 2004;292(21):2622–2631.CrossRefPubMedGoogle Scholar
  3. 3.
    Lindner A, Charra B, Sherrard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med. Mar 28 1974;290(13):697–701.CrossRefPubMedGoogle Scholar
  4. 4.
    Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. Dec 20 2006;296(23):2832–2838.CrossRefPubMedGoogle Scholar
  5. 5.
    Menacker F. Trends in cesarean rates for first births and repeat cesarean rates for low-risk women: United States, 1990–2003. Natl Vital Stat Rep. Sep 22 2005;54(4):1–8.Google Scholar
  6. 6.
    Lydon-Rochelle M, Holt VL, Easterling TR, Martin DP. Risk of uterine rupture during labor among women with a prior cesarean delivery. N Engl J Med. Jul 52001;345(1):3–8.Google Scholar
  7. 7.
    Tofovic SP, Dubey R, Salah EM, Jackson EK. 2-Hydroxyestradiol attenuates renal disease in chronic puromycin aminonucleoside nephropathy. J Am Soc Nephrol. Nov 2002;13(11):2737–2747.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.University of WashingtonSeattleUSA

Personalised recommendations